UAE Spearheads Global Fight Against Antibiotic Resistance with 7th ICAMR Conference
Dubai, The Gulf Observer: In a significant stride towards combating antibiotic resistance on a global scale, the United Arab Emirates (UAE) is set to host the 7th UAE International Conference on Antimicrobial Resistance (ICAMR), commencing tomorrow. Organized by the Ministry of Health and Prevention (MoHAP), in collaboration with the Dubai Health Authority (DHA), Emirates Health Services (EHS), and the Department of Health – Abu Dhabi, the conference is scheduled to take place in Dubai on 23rd and 24th February.
Under the esteemed patronage of Abdul Rahman bin Mohammad bin Nasser Al Owais, Minister of Health and Prevention, the event aims to create an environment conducive to the exchange of expertise and discussion. The conference seeks to promote advancements in health services while emphasizing the critical importance of continuous education and innovation in healthcare.
The two-day conference is anticipated to draw more than 600 professionals, including doctors, consultants, nurses, and technicians from the UAE and 18 other countries. Notably, 15 prominent pharmaceutical and medical device companies dedicated to combating antimicrobial resistance will actively participate.
Featuring over 38 international experts delivering 32 specialized lectures, the conference will engage participants in interactive workshops. Dr. Najiba Abdul Razzaq, Conference Chair and Consultant of Internal Medicine at Kuwait Hospital in Dubai, part of Emirates Health Services (EHS), emphasized that the 7th edition of ICAMR serves as an ideal platform for healthcare professionals worldwide to address the urgent challenges of antibiotic resistance. It provides a space to share the latest research and innovations in antimicrobial treatments.
The conference will offer participants a unique opportunity to exchange knowledge and experiences, fostering the adoption of fresh therapeutic strategies. With the World Health Organization (WHO) warning that antibiotic resistance causes 700,000 deaths annually—a number projected to surge to 10 million by 2050—the 7th ICAMR emerges as a crucial initiative to raise awareness and enhance medical competencies in tackling this looming global health crisis.
